SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Abbott‘s VP of Neuromodulation Ryan Lakin discusses his vision for neuromodulation and trends in the mar...
The North American Neuromodulation Society (NANS) is once again bringing together the leading clinicians...
SmartTRAK is attending the upcoming North American Neuromodulation Society meeting (NANS) in Orlando, Fl...
Amaza Reitmeier, Medtronic’s VP and GM of Brain Modulation, discusses the company’s recent FDA approvals...
ASPN Chairman Tim Deer, MD, discusses the research and innovation at ASPN 2024 and the society’s collabo...
INS President Dr. Marc Russo and INS President-Elect Dr. Konstantin Slavin discuss the current “state of...
Medtronic executives discuss how the Company is making waves in interventional pain, minimally invasive ...
The North American Neuromodulation Society (NANS) is celebrating its 30th anniversary in 2024 and is onc...
Neuromodulation companies are keeping their fingers crossed that the positive growth in Q123 is a sign t...
SmartTRAK’s survey of interventional pain physicians reveals valuable insights into current and future t...
Login